+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eucrisa"

From
EUCRISA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EUCRISA Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
From
Eucrisa- Drug Insight, 2019 - Product Thumbnail Image

Eucrisa- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Eucrisa is a topical medication used to treat mild to moderate atopic dermatitis (eczema) in adults and children two years of age and older. It is a corticosteroid-free, non-steroidal, topical cream that works by blocking the release of certain inflammatory substances in the body. Eucrisa is the first and only FDA-approved topical medication for atopic dermatitis that does not contain a corticosteroid. Eucrisa is a relatively new drug in the dermatological market, but it has quickly become a popular treatment option for those suffering from atopic dermatitis. It is a safe and effective alternative to corticosteroid-based treatments, and it has been shown to reduce the severity of symptoms and improve quality of life for those with atopic dermatitis. The Eucrisa market is comprised of a variety of companies, including Pfizer, Inc., Galderma Laboratories, L.P., and Valeant Pharmaceuticals International, Inc. These companies are dedicated to providing safe and effective treatments for atopic dermatitis, and they are committed to helping those suffering from this condition. Show Less Read more